Evidence map›Paper›PMID 24983020›Full record

Trial reportRhode Island medical journal (2013)2014

HCV among The Miriam Hospital and Rhode Island Hospital Adult ED Patients.

Roland C Merchant, Janette R Baird, Tao Liu, Lynn E Taylor

Abstract readClinical Trial
In one paragraph

Trial report in Rhode Island medical journal (2013), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Trial
  2. [Establishment and implementation of hepatitis C screening and referral channels in the hospitals].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2020
    Article
  3. Article
  4. Implementation and Preliminary Results of an Emergency Department Nontargeted, Opt-out Hepatitis C Virus Screening Program.Academic emergency medicine : official journal of the Society for Academic Emergency Medicine · 2018
    Article
  5. Article
  6. Sex Differences in Substance Use Among Adult Emergency Department Patients: Prevalence, Severity, and Need for Intervention.Academic emergency medicine : official journal of the Society for Academic Emergency Medicine · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Roland C MerchantAssociate Professor of Emergency Medicine and Epidemiology at the Alpert Medical School and School of Public Health of Brown University and an attending physician at the Rhode Island Hospital Anderson Emergency Center.
Janette R BairdAssistant Professor (Research) of Emergency Medicine at the Alpert Medical School of Brown University and a research psychologist at Rhode Island Hospital.
Tao LiuAssistant Professor of Biostatistics at the School of Public Health of Brown University.
Lynn E TaylorAssistant Professor of Medicine in the Division of Infectious Diseases at the Alpert Medical School of Brown University and an HIV and viral hepatitis specialist at The Miriam Hospital Immunology Center.

Funding

Translational ScienceP30AI042853 · NIAID · MIRIAM HOSPITAL · PI CURT G BECKWITH · 1998 to 2026
$51.7M
Brief Intervention for Drug Misuse for the Emergency Department (BIDMED)R01DA026066 · NIDA · RHODE ISLAND HOSPITAL · PI MERCHANT, ROLAND C, NIRENBERG, TED D · 2009 to 2013
$3.3M
Increasing Viral Testing in the Emergency Department (InVITED)R21DA028645 · NIDA · RHODE ISLAND HOSPITAL · PI MERCHANT, ROLAND C · 2010 to 2011
$424k
NIAID NIH HHS P30 AI042853NIDA NIH HHS R01 DA026066NIDA NIH HHS R01DA026066NIDA NIH HHS R21 DA028645NIDA NIH HHS R21 DA28645
6 · The paper itself

Abstract

The Emergency Department (ED) appears to be an ideal place to conduct hepatitis C virus (HCV) screening. We aimed to estimate the prevalence of prior HCV test positivity among adult (18-64 year-old) patients at The Miriam Hospital and Rhode Island Hospital EDs, as well as the undiagnosed HCV antibody seroprevalence among patients with any self-reported injection or non-injection drug use who agreed to undergo rapid HCV antibody testing. The prevalence of prior HCV test positivity among 8,500 adult ED patients was approximately 4.6%, and the previously undiagnosed HCV antibody seroprevalence among 621 drug-using adult ED patients was 1.6%. Among the ten ED patients with a positive rapid HCV antibody test not previously diagnosed, eight were born after 1965 and six never had injected drugs. If current HCV screening recommendations were followed exclusively in this setting, this practice would have missed half of those with a positive rapid HCV antibody test.

Indexed as

AdolescentAdultEarly DiagnosisEmergency Service, HospitalFemaleHepatitis C, ChronicHospitalizationHumansMaleMiddle AgedPrevalenceRhode IslandSubstance-Related DisordersYoung Adultemergency medicinehepatitis Cmass screeningseroepidemiologic studiessubstance abuse

Identifiers

PMID24983020
PMCPMC4349365

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.